Fennec Pharmaceuticals (NASDAQ: FENC) reported Q4 EPS of ($0.17), $0.20 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $13.77 million versus the consensus estimate of $14.56 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.